ID   API5_HUMAN              Reviewed;         524 AA.
AC   Q9BZZ5; B4DGR0; B4DRJ2; B4E283; D3DR21; G3V1C3; O15441; Q9Y4J7;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 3.
DT   18-JUN-2025, entry version 177.
DE   RecName: Full=Apoptosis inhibitor 5 {ECO:0000305};
DE            Short=API-5;
DE   AltName: Full=Antiapoptosis clone 11 protein;
DE            Short=AAC-11;
DE   AltName: Full=Cell migration-inducing gene 8 protein;
DE   AltName: Full=Fibroblast growth factor 2-interacting factor;
DE            Short=FIF;
DE   AltName: Full=Protein XAGL;
GN   Name=API5 {ECO:0000312|HGNC:HGNC:594}; ORFNames=MIG8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=9307294;
RA   Tewari M., Yu M., Ross B., Dean C., Giordano A., Rubin R.;
RT   "AAC-11, a novel cDNA that inhibits apoptosis after growth factor
RT   withdrawal.";
RL   Cancer Res. 57:4063-4069(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=10393420; DOI=10.1159/000015247;
RA   Gianfrancesco F., Esposito T., Ciccodicola A., D'Esposito M.,
RA   Mazzarella R., D'Urso M., Forabosco A.;
RT   "Molecular cloning and fine mapping of API5L1, a novel human gene strongly
RT   related to an antiapoptotic gene.";
RL   Cytogenet. Cell Genet. 84:164-166(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   72-524 (ISOFORM 1), IDENTIFICATION OF ISOFORM 3, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, AND INTERACTION WITH FGF2.
RC   TISSUE=Liver;
RX   PubMed=11075807; DOI=10.1210/mend.14.11.0556;
RA   Van den Berghe L., Laurell H., Huez I., Zanibellato C., Prats H.,
RA   Bugler B.;
RT   "FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear
RT   putatively antiapoptotic factor, interacts specifically with FGF-2.";
RL   Mol. Endocrinol. 14:1709-1724(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kim J.W.;
RT   "Identification of a human cell migration gene.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-276; VAL-300 AND
RP   SER-493.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4; 5 AND 6).
RC   TISSUE=Brain, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-9; 26-36; 131-148; 161-169; 244-251 AND 427-436,
RP   CLEAVAGE OF INITIATOR METHIONINE, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 384-524 (ISOFORM 3).
RX   PubMed=8889549; DOI=10.1101/gr.6.9.807;
RA   Hillier L.D., Lennon G., Becker M., Bonaldo M.F., Chiapelli B., Chissoe S.,
RA   Dietrich N., DuBuque T., Favello A., Gish W., Hawkins M., Hultman M.,
RA   Kucaba T., Lacy M., Le M., Le N., Mardis E., Moore B., Morris M.,
RA   Parsons J., Prange C., Rifkin L., Rohlfing T., Schellenberg K.,
RA   Bento Soares M., Tan F., Thierry-Meg J., Trevaskis E., Underwood K.,
RA   Wohldman P., Waterston R., Wilson R., Marra M.;
RT   "Generation and analysis of 280,000 human expressed sequence tags.";
RL   Genome Res. 6:807-828(1996).
RN   [13]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10780674; DOI=10.1038/labinvest.3780063;
RA   Kim J.W., Cho H.S., Kim J.H., Hur S.Y., Kim T.E., Lee J.M., Kim I.K.,
RA   Namkoong S.E.;
RT   "AAC-11 overexpression induces invasion and protects cervical cancer cells
RT   from apoptosis.";
RL   Lab. Invest. 80:587-594(2000).
RN   [14]
RP   TISSUE SPECIFICITY.
RX   PubMed=11557113; DOI=10.1016/s0169-5002(01)00213-6;
RA   Sasaki H., Moriyama S., Yukiue H., Kobayashi Y., Nakashima Y., Kaji M.,
RA   Fukai I., Kiriyama M., Yamakawa Y., Fujii Y.;
RT   "Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in
RT   non-small cell lung cancer.";
RL   Lung Cancer 34:53-57(2001).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [16]
RP   FUNCTION.
RX   PubMed=17112319; DOI=10.1371/journal.pgen.0020196;
RA   Morris E.J., Michaud W.A., Ji J.Y., Moon N.S., Rocco J.W., Dyson N.J.;
RT   "Functional identification of Api5 as a suppressor of E2F-dependent
RT   apoptosis in vivo.";
RL   PLoS Genet. 2:E196-E196(2006).
RN   [17]
RP   TISSUE SPECIFICITY.
RX   PubMed=17827341; DOI=10.1189/jlb.0607425;
RA   Krejci P., Pejchalova K., Rosenbloom B.E., Rosenfelt F.P., Tran E.L.,
RA   Laurell H., Wilcox W.R.;
RT   "The antiapoptotic protein Api5 and its partner, high molecular weight
RT   FGF2, are up-regulated in B cell chronic lymphoid leukemia.";
RL   J. Leukoc. Biol. 82:1363-1364(2007).
RN   [18]
RP   FUNCTION, INTERACTION WITH ACIN1, AND TISSUE SPECIFICITY.
RX   PubMed=19387494; DOI=10.1038/emboj.2009.106;
RA   Rigou P., Piddubnyak V., Faye A., Rain J.-C., Michel L., Calvo F.,
RA   Poyet J.-L.;
RT   "The antiapoptotic protein AAC-11 interacts with and regulates Acinus-
RT   mediated DNA fragmentation.";
RL   EMBO J. 28:1576-1588(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-462 AND SER-464, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-399, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-500, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-498 OF WILD-TYPE AND MUTANT
RP   GLN-251, NUCLEAR LOCALIZATION SIGNAL, ACETYLATION AT LYS-251, REPEATS, AND
RP   SUBUNIT.
RX   PubMed=22334682; DOI=10.1074/jbc.m111.317594;
RA   Han B.G., Kim K.H., Lee S.J., Jeong K.C., Cho J.W., Noh K.H., Kim T.W.,
RA   Kim S.J., Yoon H.J., Suh S.W., Lee S., Lee B.I.;
RT   "Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein
RT   interaction modules.";
RL   J. Biol. Chem. 287:10727-10737(2012).
CC   -!- FUNCTION: Antiapoptotic factor that may have a role in protein
CC       assembly. Negatively regulates ACIN1. By binding to ACIN1, it
CC       suppresses ACIN1 cleavage from CASP3 and ACIN1-mediated DNA
CC       fragmentation. Also known to efficiently suppress E2F1-induced
CC       apoptosis. Its depletion enhances the cytotoxic action of the
CC       chemotherapeutic drugs. {ECO:0000269|PubMed:10780674,
CC       ECO:0000269|PubMed:17112319, ECO:0000269|PubMed:19387494}.
CC   -!- SUBUNIT: Monomer. Interacts with FGF2 and ACIN1.
CC       {ECO:0000269|PubMed:11075807, ECO:0000269|PubMed:19387494,
CC       ECO:0000269|PubMed:22334682}.
CC   -!- INTERACTION:
CC       Q9BZZ5; Q9UKV3-3: ACIN1; NbExp=2; IntAct=EBI-1048422, EBI-6976596;
CC       Q9BZZ5; Q13838: DDX39B; NbExp=2; IntAct=EBI-1048422, EBI-348622;
CC       Q9BZZ5-2; Q9UBB4: ATXN10; NbExp=3; IntAct=EBI-10989614, EBI-702390;
CC       Q9BZZ5-2; A1A5D9: BICDL2; NbExp=3; IntAct=EBI-10989614, EBI-10171799;
CC       Q9BZZ5-2; P19404: NDUFV2; NbExp=3; IntAct=EBI-10989614, EBI-713665;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11075807}. Cytoplasm
CC       {ECO:0000269|PubMed:11075807}. Note=Mainly nuclear. Can also be
CC       cytoplasmic.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=4;
CC         IsoId=Q9BZZ5-4; Sequence=Displayed;
CC       Name=1; Synonyms=FIF-510;
CC         IsoId=Q9BZZ5-1; Sequence=VSP_041969, VSP_041972;
CC       Name=2; Synonyms=FIF-504;
CC         IsoId=Q9BZZ5-2; Sequence=VSP_041970, VSP_041971;
CC       Name=3; Synonyms=FIF C1;
CC         IsoId=Q9BZZ5-3; Sequence=VSP_039761, VSP_039762;
CC       Name=5;
CC         IsoId=Q9BZZ5-5; Sequence=VSP_043289, VSP_041970, VSP_041971;
CC       Name=6;
CC         IsoId=Q9BZZ5-6; Sequence=VSP_057412;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested, including heart,
CC       brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.
CC       Highest levels in heart, pancreas and placenta. Highly expressed in
CC       several cancers. Preferentially expressed in squamous cell carcinoma
CC       versus adenocarcinoma in non-small cell lung cancer.
CC       {ECO:0000269|PubMed:10780674, ECO:0000269|PubMed:11075807,
CC       ECO:0000269|PubMed:11557113, ECO:0000269|PubMed:17827341,
CC       ECO:0000269|PubMed:19387494}.
CC   -!- DOMAIN: Two regions, an N-terminal (aa 96-107) and a C-terminal (aa
CC       274-311) are required for binding FGF2.
CC   -!- PTM: Acetylation at Lys-251 impairs antiapoptotic function.
CC       {ECO:0000269|PubMed:22334682}.
CC   -!- SIMILARITY: Belongs to the API5 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB86528.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAB86528.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U83857; AAB86528.1; ALT_SEQ; mRNA.
DR   EMBL; Y15906; CAA75867.1; -; mRNA.
DR   EMBL; AF229253; AAK00737.1; -; mRNA.
DR   EMBL; AF229254; AAK00738.1; -; mRNA.
DR   EMBL; AY311389; AAQ76714.1; -; mRNA.
DR   EMBL; BT007093; AAP35756.1; -; mRNA.
DR   EMBL; AY265973; AAO89077.1; -; Genomic_DNA.
DR   EMBL; AK294724; BAG57871.1; -; mRNA.
DR   EMBL; AK299288; BAG61304.1; -; mRNA.
DR   EMBL; AK304157; BAG65045.1; -; mRNA.
DR   EMBL; AC087276; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68098.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68099.1; -; Genomic_DNA.
DR   EMBL; BC017709; AAH17709.1; -; mRNA.
DR   EMBL; W40304; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS31465.1; -. [Q9BZZ5-2]
DR   CCDS; CCDS44572.1; -. [Q9BZZ5-4]
DR   CCDS; CCDS44573.1; -. [Q9BZZ5-5]
DR   RefSeq; NP_001136402.1; NM_001142930.2. [Q9BZZ5-4]
DR   RefSeq; NP_001136403.1; NM_001142931.2. [Q9BZZ5-5]
DR   RefSeq; NP_001230676.1; NM_001243747.1.
DR   RefSeq; NP_006586.1; NM_006595.4. [Q9BZZ5-2]
DR   PDB; 3U0R; X-ray; 2.50 A; A=1-498.
DR   PDB; 3V6A; X-ray; 2.60 A; A=1-454.
DR   PDB; 6L4O; X-ray; 2.60 A; A=1-524.
DR   PDBsum; 3U0R; -.
DR   PDBsum; 3V6A; -.
DR   PDBsum; 6L4O; -.
DR   AlphaFoldDB; Q9BZZ5; -.
DR   SMR; Q9BZZ5; -.
DR   BioGRID; 114109; 195.
DR   CORUM; Q9BZZ5; -.
DR   FunCoup; Q9BZZ5; 5479.
DR   IntAct; Q9BZZ5; 45.
DR   MINT; Q9BZZ5; -.
DR   STRING; 9606.ENSP00000431391; -.
DR   GlyGen; Q9BZZ5; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9BZZ5; -.
DR   PhosphoSitePlus; Q9BZZ5; -.
DR   SwissPalm; Q9BZZ5; -.
DR   BioMuta; API5; -.
DR   DMDM; 353526346; -.
DR   jPOST; Q9BZZ5; -.
DR   MassIVE; Q9BZZ5; -.
DR   PaxDb; 9606-ENSP00000431391; -.
DR   PeptideAtlas; Q9BZZ5; -.
DR   ProteomicsDB; 32325; -.
DR   ProteomicsDB; 79926; -. [Q9BZZ5-4]
DR   ProteomicsDB; 79927; -. [Q9BZZ5-1]
DR   ProteomicsDB; 79928; -. [Q9BZZ5-2]
DR   ProteomicsDB; 79929; -. [Q9BZZ5-3]
DR   ProteomicsDB; 79930; -. [Q9BZZ5-5]
DR   Pumba; Q9BZZ5; -.
DR   Antibodypedia; 13145; 290 antibodies from 33 providers.
DR   DNASU; 8539; -.
DR   Ensembl; ENST00000378852.7; ENSP00000368129.3; ENSG00000166181.13. [Q9BZZ5-2]
DR   Ensembl; ENST00000420461.6; ENSP00000402540.2; ENSG00000166181.13. [Q9BZZ5-5]
DR   Ensembl; ENST00000455725.6; ENSP00000399341.2; ENSG00000166181.13. [Q9BZZ5-6]
DR   Ensembl; ENST00000531273.6; ENSP00000431391.1; ENSG00000166181.13. [Q9BZZ5-4]
DR   Ensembl; ENST00000534600.5; ENSP00000434462.1; ENSG00000166181.13. [Q9BZZ5-1]
DR   GeneID; 8539; -.
DR   KEGG; hsa:8539; -.
DR   MANE-Select; ENST00000531273.6; ENSP00000431391.1; NM_001142930.2; NP_001136402.1.
DR   UCSC; uc001mxf.3; human. [Q9BZZ5-4]
DR   UCSC; uc010rfg.2; human.
DR   AGR; HGNC:594; -.
DR   CTD; 8539; -.
DR   DisGeNET; 8539; -.
DR   GeneCards; API5; -.
DR   HGNC; HGNC:594; API5.
DR   HPA; ENSG00000166181; Low tissue specificity.
DR   MIM; 609774; gene.
DR   OpenTargets; ENSG00000166181; -.
DR   VEuPathDB; HostDB:ENSG00000166181; -.
DR   eggNOG; KOG2213; Eukaryota.
DR   GeneTree; ENSGT00390000010991; -.
DR   HOGENOM; CLU_037809_1_0_1; -.
DR   InParanoid; Q9BZZ5; -.
DR   OMA; RCIKFLA; -.
DR   OrthoDB; 19224at2759; -.
DR   PAN-GO; Q9BZZ5; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9BZZ5; -.
DR   PathwayCommons; Q9BZZ5; -.
DR   SignaLink; Q9BZZ5; -.
DR   BioGRID-ORCS; 8539; 68 hits in 1156 CRISPR screens.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   ChiTaRS; API5; human.
DR   EvolutionaryTrace; Q9BZZ5; -.
DR   GeneWiki; API5; -.
DR   GenomeRNAi; 8539; -.
DR   Pharos; Q9BZZ5; Tbio.
DR   PRO; PR:Q9BZZ5; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9BZZ5; protein.
DR   Bgee; ENSG00000166181; Expressed in islet of Langerhans and 218 other cell types or tissues.
DR   ExpressionAtlas; Q9BZZ5; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; ISS:UniProtKB.
DR   GO; GO:0017134; F:fibroblast growth factor binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0044346; P:fibroblast apoptotic process; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:2000270; P:negative regulation of fibroblast apoptotic process; IEA:Ensembl.
DR   DisProt; DP02894; -. [Q9BZZ5-2]
DR   FunFam; 1.25.10.10:FF:000092; apoptosis inhibitor 5 isoform X2; 1.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   InterPro; IPR008383; API5.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   PANTHER; PTHR12758:SF19; APOPTOSIS INHIBITOR 5; 1.
DR   PANTHER; PTHR12758; APOPTOSIS INHIBITOR 5-RELATED; 1.
DR   Pfam; PF05918; API5; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   neXtProt; NX_Q9BZZ5; -.
DR   PharmGKB; PA24881; -.
DR   TreeFam; TF324283; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; Cytoplasm;
KW   Direct protein sequencing; Methylation; Nucleus; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.11"
FT   CHAIN           2..524
FT                   /note="Apoptosis inhibitor 5"
FT                   /id="PRO_0000064634"
FT   REGION          2..360
FT                   /note="ARM-like and Heat-like helical repeats"
FT   REGION          370..391
FT                   /note="Leucine-zipper"
FT   REGION          452..524
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           454..475
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:22334682"
FT   COMPBIAS        462..472
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        487..497
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         251
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:22334682"
FT   MOD_RES         399
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         462
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         464
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:24275569"
FT   MOD_RES         469
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35841"
FT   MOD_RES         500
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   VAR_SEQ         1..23
FT                   /note="MPTVEELYRNYGILADATEQVGQ -> MKQRWRENGIGK (in isoform
FT                   6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057412"
FT   VAR_SEQ         24..77
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043289"
FT   VAR_SEQ         427..431
FT                   /note="DLFHI -> AKESQ (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8889549"
FT                   /id="VSP_039761"
FT   VAR_SEQ         432..510
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8889549"
FT                   /id="VSP_039762"
FT   VAR_SEQ         498..510
FT                   /note="EQRGAFRGSRGGR -> GERFRLGTRNMRD (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:11075807"
FT                   /id="VSP_041969"
FT   VAR_SEQ         499..504
FT                   /note="QRGAFR -> RSLQGK (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10393420,
FT                   ECO:0000303|PubMed:11075807, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.4,
FT                   ECO:0000303|Ref.5"
FT                   /id="VSP_041970"
FT   VAR_SEQ         505..524
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10393420,
FT                   ECO:0000303|PubMed:11075807, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.4,
FT                   ECO:0000303|Ref.5"
FT                   /id="VSP_041971"
FT   VAR_SEQ         511..524
FT                   /note="Missing (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:11075807"
FT                   /id="VSP_041972"
FT   VARIANT         276
FT                   /note="P -> S"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_021519"
FT   VARIANT         300
FT                   /note="M -> V (in dbSNP:rs5743240)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_021520"
FT   VARIANT         493
FT                   /note="G -> S (in dbSNP:rs2862934)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_021521"
FT   CONFLICT        371..373
FT                   /note="KDF -> HES (in Ref. 1; AAB86528)"
FT                   /evidence="ECO:0000305"
FT   HELIX           4..16
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           18..24
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           25..33
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           34..36
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           39..52
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           53..55
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           57..59
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           60..71
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           76..85
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           86..89
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           92..94
FT                   /evidence="ECO:0007829|PDB:6L4O"
FT   HELIX           95..105
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           111..127
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           129..142
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           145..158
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           159..161
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   TURN            164..166
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           169..182
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           183..185
FT                   /evidence="ECO:0007829|PDB:6L4O"
FT   HELIX           188..199
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           202..204
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           207..221
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   TURN            222..224
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   STRAND          229..231
FT                   /evidence="ECO:0007829|PDB:3V6A"
FT   HELIX           232..245
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           246..248
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   STRAND          251..253
FT                   /evidence="ECO:0007829|PDB:6L4O"
FT   HELIX           256..265
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           267..269
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           282..294
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           303..315
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           340..354
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           359..362
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   TURN            368..370
FT                   /evidence="ECO:0007829|PDB:3V6A"
FT   HELIX           371..395
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           402..404
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   HELIX           406..427
FT                   /evidence="ECO:0007829|PDB:3U0R"
FT   STRAND          430..432
FT                   /evidence="ECO:0007829|PDB:6L4O"
SQ   SEQUENCE   524 AA;  59005 MW;  A2EA6BE4D8318BB9 CRC64;
     MPTVEELYRN YGILADATEQ VGQHKDAYQV ILDGVKGGTK EKRLAAQFIP KFFKHFPELA
     DSAINAQLDL CEDEDVSIRR QAIKELPQFA TGENLPRVAD ILTQLLQTDD SAEFNLVNNA
     LLSIFKMDAK GTLGGLFSQI LQGEDIVRER AIKFLSTKLK TLPDEVLTKE VEELILTESK
     KVLEDVTGEE FVLFMKILSG LKSLQTVSGR QQLVELVAEQ ADLEQTFNPS DPDCVDRLLQ
     CTRQAVPLFS KNVHSTRFVT YFCEQVLPNL GTLTTPVEGL DIQLEVLKLL AEMSSFCGDM
     EKLETNLRKL FDKLLEYMPL PPEEAENGEN AGNEEPKLQF SYVECLLYSF HQLGRKLPDF
     LTAKLNAEKL KDFKIRLQYF ARGLQVYIRQ LRLALQGKTG EALKTEENKI KVVALKITNN
     INVLIKDLFH IPPSYKSTVT LSWKPVQKVE IGQKRASEDT TSGSPPKKSS AGPKRDARQI
     YNPPSGKYSS NLGNFNYEQR GAFRGSRGGR GWGTRGNRSR GRLY
//
